Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,781 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody-based targeting of BCMA in multiple myeloma.
Morgan GJ, Williams L. Morgan GJ, et al. Among authors: williams l. Lancet Oncol. 2020 Feb;21(2):186-187. doi: 10.1016/S1470-2045(19)30819-8. Lancet Oncol. 2020. PMID: 32007191 No abstract available.
Chromothripsis as a pathogenic driver of multiple myeloma.
Maura F, Boyle EM, Rustad EH, Ashby C, Kaminetzky D, Bruno B, Braunstein M, Bauer M, Blaney P, Wang Y, Ghamlouch H, Williams L, Stoeckle J, Davies FE, Walker BA, Maclachlan K, Diamond B, Landgren O, Morgan GJ. Maura F, et al. Among authors: williams l. Semin Cell Dev Biol. 2022 Mar;123:115-123. doi: 10.1016/j.semcdb.2021.04.014. Epub 2021 May 3. Semin Cell Dev Biol. 2022. PMID: 33958284 Review.
Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length.
Boyle EM, Williams L, Blaney P, Ashby C, Bauer M, Walker BA, Ghamlouch H, Choi J, Perrial E, Wang Y, Caro J, Stoeckle JH, Arbini A, Kaminetzky D, Braunstein M, Bruno B, Razzo B, Diamond B, Maclachlan K, Maura F, Landgren O, Litke R, Fegan CD, Keats J, Auclair D, Davies FE, Morgan GJ. Boyle EM, et al. Among authors: williams l. Leukemia. 2022 Jan;36(1):221-224. doi: 10.1038/s41375-021-01320-3. Epub 2021 Jun 19. Leukemia. 2022. PMID: 34148053 No abstract available.
Structural variants shape the genomic landscape and clinical outcome of multiple myeloma.
Ashby C, Boyle EM, Bauer MA, Mikulasova A, Wardell CP, Williams L, Siegel A, Blaney P, Braunstein M, Kaminetsky D, Keats J, Maura F, Landgren O, Walker BA, Davies FE, Morgan GJ. Ashby C, et al. Among authors: williams l. Blood Cancer J. 2022 May 30;12(5):85. doi: 10.1038/s41408-022-00673-x. Blood Cancer J. 2022. PMID: 35637217 Free PMC article.
The evolving role and utility of off-label drug use in multiple myeloma.
Stoeckle JH, Davies FE, Williams L, Boyle EM, Morgan GJ. Stoeckle JH, et al. Among authors: williams l. Explor Target Antitumor Ther. 2021;2(4):355-373. doi: 10.37349/etat.2021.00050. Epub 2021 Aug 30. Explor Target Antitumor Ther. 2021. PMID: 36046752 Free PMC article. Review.
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma.
Boyle EM, Blaney P, Stoeckle JH, Wang Y, Ghamlouch H, Gagler D, Braunstein M, Williams L, Tenenbaum A, Siegel A, Chen X, Varma G, Avigan J, Li A, Jinsi M, Kaminetzsky D, Arbini A, Montes L, Corre J, Rustad EH, Landgren O, Maura F, Walker BA, Bauer M, Bruno B, Tsirigos A, Davies FE, Morgan GJ. Boyle EM, et al. Among authors: williams l. Clin Cancer Res. 2023 Oct 2;29(19):3901-3913. doi: 10.1158/1078-0432.CCR-22-3209. Clin Cancer Res. 2023. PMID: 37449980
6,781 results